A.Z. SHARAFEEV^1.2, V.V. ZHAVORONKOV³, S.V. ZINCHENKO⁴, A.F. KHALIRAKHMANOV⁴

¹Chechen State University, Grozny

²Republican Clinical Hospital, Grozny

³Ministry of Health of the Republic of Tatarstan, Kazan

⁴Kazan (Volga region) Federal University, Kazan

Sharafeev A.Z. ― MD, Professor of the Department of Hospital Surgery, Head of Cardiology, Endovascular and Cardiovascular Surgery Unit

Address: 32 A. Sheripov Str., Grozny, 364030, e-mail: [email protected],

Cardio-oncology is a relatively new direction in cardiology and oncology, focused on the prevention, diagnosis, treatment and dispensary monitoring of cardiovascular diseases in cancer patients. The objective of this study is to compile information on cardio-oncology and describe the most common combinations of diseases. The article presents frequent concomitant cardiological diseases during chemotherapy and radiation therapy in patients with cancer. During the treatment of patients with malignant neoplasms complications of the cardiovascular system are frequent. The role and function of a cardio-oncologist in the correction of cardiac risks in cancer patients is also explained in the study. The treatment and supervision of patients of this group requires in-depth knowledge, both in cardiology and oncology.

Key words: cancer, cardio-oncology, chemotherapy, radiation therapy, toxicity.

 (For citation: Sharafeev A.Z., Zhavoronkov V.V., Zinchenko S.V., Khalirakhmanov A.F. Cardio-oncology ― a new direction in cardiology. Practical medicine. 2020. Vol. 18, №1, P. 38-42)

REFERENCES

1. Zamorano J.L., Lancellotti P., Rodriguez M.D., Aboyans V., Asteggiano R., Galderisi M., Habib G., Lenihan D.J., Lip G.Y.H., Lyon A.R., Lopez Fernandez T., Mohty D., Piepoli M.F., Tamargo J., Torbicki A., Suter T.M. ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J, 2016; 37:2768-801.
2. Cardonick E., Dougherty R., Grana G., Gilmandyar D., Ghaffar S., Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J, 2010;16:76-82.
3. Lancellotti P., Suter T.M., López-Fernández T., Galderisi M., Lyon A.R., Vander Meer P., Cohen Solal A., Zamorano J.L., Jerusalem G., Moonen M., Aboyans V., Bax J.J., Asteggiano R. Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council. Eur Heart J, 2018. [Epubaheadofprint].
4. Khalirakhmanov A.F., Gaziev E.A., Zinchenko S.V., Bariev N.I., Sharafeev A.Z., Ryabchikov I.V. Modern aspects of the effect of chemotherapy treatment and radiation therapy on the cardiovascular system in cancer patients. Povolzhskiy onkologicheskiy vestnik, 2018, vol.8, no. 5, pp. 51–56 (in Russ.).
5. Markus S., Anker S., von Haehling, Ulf Landmesser, Andrew J.S. Coast et al. Cancer and heart failure – more than meets the eye: common risk factors and comorbilities.  European  Journal of  Heart Failure, 2018, vol. 20, no. 10 – pp. 1382-1384.
6. Christopher M. Bianco, Sadeer G. Al-Kindi, Guilhereme H. Oliveira. Advanced heart failure therapies for cancer therapeutics-related cardiac  dysfunction. Heart Failure Clinics, 2017, vol. 13(2), pp. 327-336.
7. Banke A., Videbaek M. Schou Lars, Muller J. Incidence of cancer in patients with chronic heart failure: long-term follow-up study. European  Journal of  Heart Failure, 2016, vol. 18, no. 3, pp. 260-266.
8. Borras J.M., Albreht T., Audisio R., Briers E., Casali P., Esperou H., Grube B., Hamoir M., Henning G., Kelly J., Knox S., Nabal M., Pierotti M., Lombardo C., van Harten W., Poston G., Prades J., Sant M., Travado L., Valentini V., van de Velde C., van den Bogaert S.,van den Bulcke M., van Hoof E., van den Neucker I., Wilson R. Policy statement on multidisciplinary cancer care. Eur J Cancer, 2014; 50:475-80.
9. Parent S., Pituskin E., Paterson D.I. The cardio-oncology program: amulti disciplinary approach to the care of cancer patients with cardiovascular disease. Can J Cardiol, 2016; 32:847-51.
10. Nancarrow S.A., Booth A., Ariss S., Smith T., Enderby P., Roots A. Ten principles of good interdisciplinary teamwork. Hum Resour Health, 2013; 11:19.
11. Plana J.C., Galderisi M., Barac A., Ewer M.S., Ky B., Scherrer Crosbie M., Ganame J., Sebag I.A., Agler D.A., Badano L.P., Banchs J., Cardinale D.,Carver J., Cerqueira M., DeCara J.M., Edvardsen T., Flamm S.D., Force T., Griffin B.P., Jerusalem G.,Liu J.E., Magalhães A., Marwick T., Sanchez L.Y., Sicari R., Villarraga H.R., Lancellotti P. Expert consensus for multimodality imaginge valuation of adult patients during and after cancer therapy: are port from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J CardiovascImaging, 2014; 15:1063-93.
12. Abbas Mahabadi A., Rischpler Ch. Cardiovascular imaging in cardio-oncology. Jornal of Thoracic Disease, 2018, vol. 10, pp. 4351-4366.
13. Guha A., Amit Kumar Dey, Armanious M., Dodd K. et al. Health care utilization and mortality associated with heart failure-related admissions among cancer patients. ESC Heart Failure, 2019, vol. 6(4), pp. 733-746.
14. Brancaccio M., Piozzi F., Hirsch E., Ghigo A. Mechanismus underlying the cross-talk between heart and cancer. The Physiological Society, 2019.
15. Rudolf A. Boer, Wouter C. Meajers, Peter Meer and Dirk J. Veldhuisen. Cancer and heart disease: associations and relations. European Journal of Heart Failure, 2019.
16. Adlam D., Peake M.D. Cancer and heart disease: new bedfellows in the cardiovascular landscape. European Heart Journal-Quality of Care and Clinical Outcomes, 2017, vol. 3 (3), pp. 168-170.